Authors:
Rasmussen, T
Fink-Jensen, A
Sauerberg, P
Swedberg, MDB
Thomsen, C
Sheardown, MJ
Jeppesen, L
Calligaro, DO
DeLapp, NW
Whitesitt, C
Ward, JS
Shannon, HE
Bymaster, FP
Citation: T. Rasmussen et al., The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance, SCHIZOPHR R, 49(1-2), 2001, pp. 193-201
Authors:
Christopoulos, A
Grant, MKO
Ayoubzadeh, N
Kim, ON
Sauerberg, P
Jeppesen, L
El-Fakahany, EE
Citation: A. Christopoulos et al., Synthesis and pharmacological evaluation of dimeric muscarinic acetylcholine receptor agonists, J PHARM EXP, 298(3), 2001, pp. 1260-1268
Authors:
Shannon, HE
Rasmussen, K
Bymaster, FP
Hart, JC
Peters, SC
Swedberg, MDB
Jeppesen, L
Sheardown, MJ
Sauerberg, P
Fink-Jensen, A
Citation: He. Shannon et al., Xanomeline, an M-1/M-4 preferring muscarinic cholinergic receptor agonist,produces antipsychotic-like activity in rats and mice, SCHIZOPHR R, 42(3), 2000, pp. 249-259
Authors:
Rasmussen, T
Sauerberg, P
Nielsen, EB
Swedberg, MDB
Thomsen, C
Sheardown, MJ
Jeppesen, L
Calligaro, DO
DeLapp, NW
Whitesitt, C
Ward, JS
Shannon, HE
Bymaster, FP
Fink-Jensen, A
Citation: T. Rasmussen et al., Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice, EUR J PHARM, 402(3), 2000, pp. 241-246
Citation: B. Ahren et al., Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice, AM J P-ENDO, 40(1), 1999, pp. E93-E102
Authors:
Bymaster, FP
Shannon, HE
Rasmussen, K
DeLapp, NW
Ward, JS
Calligaro, DO
Mitch, CH
Whitesitt, C
Ludvigsen, TS
Sheardown, M
Swedberg, M
Rasmussen, T
Olesen, PH
Jeppesen, L
Sauerberg, P
Fink-Jensen, A
Citation: Fp. Bymaster et al., Potential role of muscarinic receptors in schizophrenia, LIFE SCI, 64(6-7), 1999, pp. 527-534
Authors:
Shannon, HE
Hart, JC
Bymaster, FP
Calligaro, DO
Delapp, NW
Mitch, CH
Ward, JS
Fink-Jensen, A
Sauerberg, P
Jeppesen, L
Sheardown, MJ
Swedberg, MDB
Citation: He. Shannon et al., Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats, J PHARM EXP, 290(2), 1999, pp. 901-907
Authors:
Jeppesen, L
Olesen, PH
Hansen, L
Sheardown, MJ
Thomsen, C
Rasmussen, T
Jensen, AF
Christensen, MS
Rimvall, K
Ward, JS
Whitesitt, C
Calligaro, DO
Bymaster, FP
Delapp, NW
Felder, CC
Shannon, HE
Sauerberg, P
Citation: L. Jeppesen et al., 1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives, J MED CHEM, 42(11), 1999, pp. 1999-2006
Authors:
Fink-Jensen, A
Kristensen, P
Shannon, HE
Calligaro, DO
Delapp, NW
Whitesitt, C
Ward, JS
Thomsen, C
Rasmusseen, T
Sheardown, MJ
Jeppesen, L
Sauerberg, P
Bymaster, FP
Citation: A. Fink-jensen et al., Muscarinic agonists exhibit functional dopamine antagonism in unilaterally6-OHDA lesioned rats, NEUROREPORT, 9(15), 1998, pp. 3481-3486